Rare disease patients caught up in overseas research funding cuts
Mid-April was a nerve-racking time to arrive on the National Institutes of Health campus outside Washington, D.C. — it…
FDA clears way for Sarepta Therapeutics to use Duchenne drug in some patients
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Sarepta Therapeutics’ Elevidys faces ‘arduous’ path back to market
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Global Pharmaceutical Market Projected to Hit $2.2 Trillion by 2029
BCC Research LLC “Driven by Innovation in Biologics and Expanding Therapeutic Applications, the Global Pharmaceutical Drugs Market Continues…
Sarepta will stop shipping Elevidys, Duchenne gene therapy
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Benefit Lunch for Local Baby with Rare Genetic Disorder | Local News
The Bledsoe County Rescue Squad will host a benefit lunch in Pikeville for a local infant diagnosed with…